GeneFerm Biotechnology Co., Ltd. (1796.TWO)

TWD 47.1

(-1.26%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 793.77 Million 633.96 Million 522.33 Million 368.3 Million 328.23 Million
Cost of Revenue 507.41 Million 411.8 Million 329.68 Million 246.32 Million 250.69 Million
Gross Profit 286.35 Million 222.16 Million 192.65 Million 121.97 Million 77.53 Million
Operating Expenses 132.78 Million 120.89 Million 112.37 Million 103.93 Million 100.91 Million
Selling, General and Administrative Expenses 104.45 Million 96.7 Million 88.81 Million 81.52 Million 78.77 Million
Research and Development Expenses 28.33 Million 24.18 Million 23.56 Million 22.4 Million 22.13 Million
Other Expenses - 11.71 Million -1.33 Million -701 Thousand -
Cost and Expenses 640.2 Million 532.69 Million 442.05 Million 350.25 Million 351.6 Million
Operating Income 153.56 Million 113.31 Million 79.15 Million 17.51 Million -23.37 Million
Interest Expense 4.17 Million 3.82 Million 7.31 Million 9.82 Million 9.75 Million
Income Tax Expense 28.81 Million 16.75 Million 12.98 Million 2.24 Million -5.08 Million
Earnings before Tax 153.43 Million 110.21 Million 70.39 Million 6.76 Million -32.63 Million
Net Income 124.62 Million 93.45 Million 57.41 Million 4.52 Million -27.55 Million
Earnings Per Share Basic 3.01 2.26 1.45 0.16 -0.99
Earnings Per Share Diluted 2.99 2.20 1.32 0.16 -0.99
Weighted Average Shares Outstanding 41.46 Million 41.34 Million 39.67 Million 27.89 Million 27.85 Million
Weighted Average Shares Outstanding (Diluted) 41.61 Million 42.57 Million 46.28 Million 27.9 Million 27.85 Million
Gross Margin 0.36 0.35 0.37 0.33 0.24
EBIT Margin 0.29 0.26 0.24 0.16 0.04
Profit Margin 0.16 0.15 0.11 0.01 -0.08
EBITDA 231.09 Million 163.34 Million 124.51 Million 58.58 Million 14.64 Million
Earnings Before Tax Margin 0.19 0.18 0.15 0.05 -0.07

Income Statement Charts